<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03984279</url>
  </required_header>
  <id_info>
    <org_study_id>P/2018/362</org_study_id>
    <nct_id>NCT03984279</nct_id>
  </id_info>
  <brief_title>Comparison of Sequential Fluoroscopy Guidance With Spiral Guidance in Terms of Safety, Effectiveness, Speed and Radiation in Interventional Chest-abdomen-pelvic Procedures</brief_title>
  <acronym>APIR-TDM</acronym>
  <official_title>Comparison of the Study Was to Compare Sequential Fluoroscopy Guidance With Spiral Guidance in Terms of Safety (Number of Major Complications), Effectiveness (Number of Targets Reached), Speed (Procedural Time) and Radiation (DLP) in Interventional Chest-abdomen-pelvic Procedures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study was to compare sequential fluoroscopy guidance with spiral guidance
      in terms of safety (number of major complications), effectiveness (number of targets
      reached), speed (procedural time) and radiation (DLP) in interventional chest-abdomen-pelvic
      procedures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 17, 2018</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of major complications</measure>
    <time_frame>All patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control performed on a period of 1 year will be taken into account</time_frame>
    <description>Comparison between the 2 groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of targets reached</measure>
    <time_frame>All patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control performed on a period of 1 year will be taken into account</time_frame>
    <description>Comparison between the 2 groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dose Length Product (DLP)</measure>
    <time_frame>All patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control performed on a period of 1 year will be taken into account</time_frame>
    <description>Comparison between the 2 groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of controls required to place the needle</measure>
    <time_frame>All patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control performed on a period of 1 year will be taken into account</time_frame>
    <description>Comparison between the 2 groups</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">385</enrollment>
  <condition>Body Interventional procédures With CT</condition>
  <arm_group>
    <arm_group_label>Sequentiel group (SEQ)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Siral group (SPI)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control</intervention_name>
    <description>Not applicable, all patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control on a period of 1 year will be taken into account</description>
    <arm_group_label>Sequentiel group (SEQ)</arm_group_label>
    <arm_group_label>Siral group (SPI)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with indication of interventional percutaneous diagnostic or therapeutic
        chest-abdomen-pelvic procedure under CT control
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients (&gt; 18 years),

          -  indication of interventional percutaneous diagnostic or therapeutic
             chest-abdomen-pelvic procedure under CT control

        Exclusion Criteria:

          -  MRI contra indication

          -  persons referred to in Articles L1121-5 to L1121-8 of the French Public Health Code
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 27, 2019</study_first_submitted>
  <study_first_submitted_qc>June 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2019</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

